Chuang Yi Biotech co., ltd. reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 73.05 million compared to TWD 80.67 million a year ago. Revenue was TWD 70.02 million compared to TWD 78.3 million a year ago.

Net loss was TWD 19.34 million compared to TWD 16.53 million a year ago. Basic loss per share from continuing operations was TWD 1.2766 compared to TWD 1.0974 a year ago. Diluted loss per share from continuing operations was TWD 1.2766 compared to TWD 1.0974 a year ago.